I have Type 2 diabetes. I take metformin and a shot with 8 units of insulin. My cardiologist and endocrinologist now say that I can stop taking insulin and switch to a weekly shot of Mounjaro, or I ...

The odor and discharge are strongly suggestive of a bacterial sinus infection. COVID infections, like all viral infections, can predispose a person to bacterial sinus infections. Your regular doctor ...

Novo Nordisk will slash U.S. list prices of its blockbuster diabetes and weight-loss drugs Ozempic and Wegovy by up to 50 ...

The odor and discharge are strongly suggestive of a bacterial sinus infection. COVID infections, like all viral infections, ...

I am a 49-year-old woman who recently had COVID. When I was sick with it, I lost my sense of taste and smell. I no longer have COVID, but I still have a stuffy nose with no sense of taste or smell.

Ozempic (R) was approved by Health Canada in 2018. Ozempic (R) is indicated for the once-weekly treatment of adult patients with type 2 diabetes mellitus to improve glycemic control.

Cost-effectiveness is highly price-sensitive; lower U.S. prices, particularly approaching European levels, shift semaglutide toward favorable value rather than a binary go/no-go determination. Patient ...

In a move expected to benefit thousands of New Jersey residents living with obesity and type 2 diabetes, Novo Nordisk, whose U.S. headquarters is based in Plainsboro, announced it will significantly ...

Drugmaker Lilly said its experimental pill, orforglipron, produced better blood sugar and weight loss for diabetes patients results in a new head-to-head clinical trial.

An investigational oral glucagon-like peptide-1 (GLP-1) receptor agonist, orforglipron (Eli Lilly), demonstrated superior ...

Copyright: © 2024 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.

On February 25, RBC Capital initiated coverage of Eli Lilly and Company (NYSE:LLY) with an Outperform rating and a $1,250 price target.